SCHEMBL1965860

SCHEMBL1965860

CCCCCCCCc1cccc(OPOc2cccc(CCCCCCCC)c2CCCCCCCC)c1CCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.50
ALOX5 P09917 1/20 0.50
PPARA Q07869 3/20 0.48
PPARG P37231 2/20 0.46
LIPG Q9Y5X9 1/20 0.44
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
KCNH2 Q12809 1/20 0.43
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
KAT5 Q92993 1/20 0.41
SAE1 Q9UBE0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4446465 1.00 PTGS2 (0.50) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL6743239 1.00 PTGS2 (0.50) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL4443929 1.00 PTGS2 (0.50) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL6745885 1.00 PTGS2 (0.50) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL4454133 1.00 PTGS2 (0.50) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL6855098 0.95 THRA (0.47) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL6742752 0.93 PTGS2 (0.45) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL28473665 0.90 PTGS2 (0.44) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL6743244 0.88 PTGS2 (0.51) PTGS2ALOX5PPARAPPARGLIPG
SCHEMBL4446469 0.88 PTGS2 (0.51) PTGS2ALOX5PPARAPPARGLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336217-B1 POLYESTER POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYESTER USING SAME TORAY INDUSTRIES (JP) 2015-01-14 EP disclosed
US-8816041-B2 Polyester polymerization catalyst and method for producing polyester using the same TORAY INDUSTRIES, INC. (JP) 2014-08-26 US disclosed
US-20110178265-A1 POLYESTER POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYESTER USING THE SAME TORAY INDUSTRIES, INC. (JP) 2011-07-21 US disclosed
EP-2336217-A1 POLYESTER POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYESTER USING SAME Toray Industries, Inc. (JP) 2011-06-22 EP disclosed
US-6790914-B2 TRANSPARENT (CROSSLINKED) RESIN FILM CAN BE USED AS A POLARIZING FILM, SURFACE PROTECTIVE FILM, RETARDATION FILM, TRANSPARENT CONDUCTIVE FILM, LIGHT DIFFUSION FILM, FILM FOR AN EL DISPLAY DEVICE, TRANSPARENT CONDUCTIVE COMPOSITE MATERIAL, JSR CORPORATION (JP) 2004-09-14 US disclosed
US-20040106740-A1 Resin film and applications thereof JSR CORPORATION (JP) 2004-06-03 US disclosed
EP-1195397-B1 Composition of cyclic olefin addition copolymer and cross-linked material JSR CORP (JP) 2004-04-14 EP disclosed
US-20020042461-A1 Composition of cyclic olefin addition copolymer and cross-linked material JSR CORPORATION (JP) 2002-04-11 US disclosed
EP-1195397-A1 Composition of cyclic olefin addition copolymer and cross-linked material JSR Corporation (JP) 2002-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178265-A1 POLYESTER POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYESTER USING THE SAME MGAM, MANBA, MAN2A1 PTGS2 1787/4885ALOX5 3052/4885PPARA 4600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.